EquityFlowCompanies › Speclipse

Speclipse

Healthtech · Seoul, KR

Non-invasive skin-cancer diagnosis using laser spectroscopy and AI (Spectra-Scope)

Funding history

DateRoundAmount
Aug 2021Funding round
Speclipse, a Korean medical-diagnostics company (Spectra-Scope), raised KRW 9B.

Similar companies in Healthtech

Explore funding flow on EquityFlow →